Sandoz files seven ANDAs of drugs going off-patent
Mumbai-based Sandoz Private—a wholly-owned subsidiary of Novartis AG—has applied for seven Abbreviated New Drug Applicatons (ANDAs) for products likely to go off-patent in the next three to five years.

Glaxo in-licenses Eisai’s Paritec in India
GlaxoSmithKline Pharmaceuticals (GSK) has in-licensed Paritec (rabeprazole sodium) from Eisai Pharmaceuticals India to co-promote it in India.

Drug makers spread wings abroad with new partners
No longer able to rely on selling copycats of drugs patented abroad, more Indian drug makers have begun setting up foreign partnerships to expand into overseas markets.

Chiltern launches global EDC solutions
Leading clinical research organisation Chiltern International, catering to the global demand for information, training and guidance on Electronic Data Capture, has launched a new service — EDC Solutions, according to a release issued by the company.

Waters named leading Analytical Instrumentation Company of the Year
Frost & Sullivan will present its 2005 Leading Analytical Instrumentation Company of the Year Award at the third annual Excellence in Industrial Technologies Banquet to Waters Corporation in recognition of the company’s outstanding contribution to the analytical and scientific instrumentation market, said a release issued by the company.